Black Rock Inc. Aurinia Pharmaceuticals Inc. Call Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AUPH
# of Institutions
255Shares Held
61.1MCall Options Held
977KPut Options Held
616K-
Tang Capital Management LLC San Diego, CA10MShares$157 Million5.09% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$62.2 Million2.79% of portfolio
-
State Street Corp Boston, MA2.8MShares$43.8 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.4MShares$37.6 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY1.63MShares$25.6 Million0.24% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $2.22B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...